Table 4.

One-way sensitivity analysis.

Intervention arm: varying the probabilities of mortality
Scenario 1	Using the lower bound mortality for arrythmia		Scenario 2	Using the upper bound mortality for arrythmia
Probability	0.167		Probability	0.25
ICER	2323.56		ICER	2323.56
Scenario 3	Using the lower bound mortality for action sequence conduction defect		Scenario 4	Using the upper bound mortality for action sequence conduction defect
Probability	0.032		Probability	0.048
ICER	2325.37		ICER	2325.37
Scenario 5	Using the lower bound mortality for hypertrophy		Scenario 6	Using the upper bound mortality for hypertrophy
Probability	0.083		Probability	0.125
ICER	2325.67		ICER	2325.67
Scenario 7	Using the lower bound mortality for MI		Scenario 8	Using the upper bound mortality for MI
Probability	0.074		Probability	0.111
ICER	2325.03		ICER	2325.03
Intervention arm: varying the cost of intervention with lower bounds (assumption: early screening will lead to early diagnosis and reduced cost of care)
Scenario 9: Arrhythmia	Cost: 1,15,478.85	ICER	2,294.81
Scenario 10: Conduction defect	Cost: 70,078	ICER	1,519.68
Scenario 11: Hypertrophy	Cost: 1,51,728.85	ICER	2,302.58
Scenario 12: MI	Cost: 1,27,578	ICER	2,171.17
Control arm: varying the cost of treatment with upper bounds (assumption: delayed diagnosis may lead to identification in later stage of disease leading
to higher cost of care)
Scenario 9: Arrhythmia	Cost: 2,15,339	ICER	2,320.55
Scenario 10: Conduction defect	Cost: 4,77,339	ICER	2,320.55
Scenario 11: Hypertrophy	Cost: 1,94,139	ICER	2,320.55
Scenario 12: MI	Cost: 2,15,339	ICER	2,293.46